CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.

Oncotarget · 2018 · PMC5788664 · PMID 29416796

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP=0.090so close (0.05 < p ≤ 0.1)

On the other hand, ALDH1- positivity showed a trend for 5-year relapse in univariate analysis (P=0.090).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.